310 related articles for article (PubMed ID: 24832864)
1. Using poisons information service data to assess the acute harms associated with novel psychoactive substances.
Wood DM; Hill SL; Thomas SH; Dargan PI
Drug Test Anal; 2014; 6(7-8):850-60. PubMed ID: 24832864
[TBL] [Abstract][Full Text] [Related]
2. Novel psychoactive substances: how to understand the acute toxicity associated with the use of these substances.
Wood DM; Dargan PI
Ther Drug Monit; 2012 Aug; 34(4):363-7. PubMed ID: 22673201
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists: a report from the United Kingdom National Poisons Information Service.
Waugh J; Najafi J; Hawkins L; Hill SL; Eddleston M; Vale JA; Thompson JP; Thomas SH
Clin Toxicol (Phila); 2016 Jul; 54(6):512-8. PubMed ID: 27091041
[TBL] [Abstract][Full Text] [Related]
4. Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN).
Dines AM; Wood DM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; Sedefov R; Dargan PI;
Clin Toxicol (Phila); 2015 Nov; 53(9):893-900. PubMed ID: 26503789
[TBL] [Abstract][Full Text] [Related]
5. Understanding how data triangulation identifies acute toxicity of novel psychoactive drugs.
Wood DM; Dargan PI
J Med Toxicol; 2012 Sep; 8(3):300-3. PubMed ID: 22581465
[TBL] [Abstract][Full Text] [Related]
6. Patterns of presentation and clinical features of toxicity after reported use of ([2-aminopropyl]-2,3-dihydrobenzofurans), the 'benzofuran' compounds. A report from the United Kingdom National Poisons Information Service.
Kamour A; James D; Lupton DJ; Cooper G; Eddleston M; Vale A; Thompson JP; Thanacoody R; Hill SL; Thomas SH
Clin Toxicol (Phila); 2014 Dec; 52(10):1025-31. PubMed ID: 25345418
[TBL] [Abstract][Full Text] [Related]
7. 'Ivory wave' toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoning.
Murray DB; Potts S; Haxton C; Jackson G; Sandilands EA; Ramsey J; Puchnarewicz M; Holt DW; Johnston A; Nicholas Bateman D; Dear JW
Clin Toxicol (Phila); 2012 Feb; 50(2):108-13. PubMed ID: 22224933
[TBL] [Abstract][Full Text] [Related]
8. Effect of the UK Psychoactive Substances Act 2016 on episodes of toxicity related to new psychoactive substances as reported to the National Poisons Information Service. A time series analysis.
Al-Banaa I; Hawkins L; Hill SL; Lupton DJ; Jackson G; Sandilands EA; Bradberry SM; Thompson JP; Rushton S; Thomas SHL
Int J Drug Policy; 2020 Mar; 77():102672. PubMed ID: 32032867
[TBL] [Abstract][Full Text] [Related]
9. What evidence is there that the UK should tackle the potential emerging threat of methamphetamine toxicity rather than established recreational drugs such as MDMA ('ecstasy')?
Wood DM; Button J; Ashraf T; Walker S; Greene SL; Drake N; Ramsey J; Holt DW; Dargan PI
QJM; 2008 Mar; 101(3):207-13. PubMed ID: 18222986
[TBL] [Abstract][Full Text] [Related]
10. Patterns of Acute Toxicity Associated with New Psychoactive Substances.
Hill SL; Dargan PI
Handb Exp Pharmacol; 2018; 252():475-494. PubMed ID: 29896654
[TBL] [Abstract][Full Text] [Related]
11. Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations.
Heyerdahl F; Hovda KE; Giraudon I; Yates C; Dines AM; Sedefov R; Wood DM; Dargan PI
Clin Toxicol (Phila); 2014 Dec; 52(10):1005-12. PubMed ID: 25361166
[TBL] [Abstract][Full Text] [Related]
12. Underestimated impact of novel psychoactive substances: laboratory confirmation of recreational drug toxicity in Oslo, Norway.
Vallersnes OM; Persett PS; Øiestad EL; Karinen R; Heyerdahl F; Hovda KE
Clin Toxicol (Phila); 2017 Aug; 55(7):636-644. PubMed ID: 28406320
[TBL] [Abstract][Full Text] [Related]
13. The impact of Australian legislative changes on synthetic cannabinoid exposures reported to the New South Wales Poisons Information Centre.
Cairns R; Brown JA; Gunja N; Buckley NA
Int J Drug Policy; 2017 May; 43():74-82. PubMed ID: 28343112
[TBL] [Abstract][Full Text] [Related]
14. Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.
Hill SL; Najafi J; Dunn M; Acheampong P; Kamour A; Grundlingh J; Blain PG; Thomas SH
Clin Toxicol (Phila); 2016 Sep; 54(8):638-43. PubMed ID: 27251903
[TBL] [Abstract][Full Text] [Related]
15. Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine.
Helander A; Beck O; Bäckberg M
Clin Toxicol (Phila); 2015 Jun; 53(5):446-53. PubMed ID: 25881797
[TBL] [Abstract][Full Text] [Related]
16. Trend analysis of anonymised pooled urine from portable street urinals in central London identifies variation in the use of novel psychoactive substances.
Archer JR; Dargan PI; Lee HM; Hudson S; Wood DM
Clin Toxicol (Phila); 2014 Mar; 52(3):160-5. PubMed ID: 24506433
[TBL] [Abstract][Full Text] [Related]
17. The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone).
Dargan PI; Sedefov R; Gallegos A; Wood DM
Drug Test Anal; 2011; 3(7-8):454-63. PubMed ID: 21755604
[TBL] [Abstract][Full Text] [Related]
18. Change in the new psychoactive substances associated with Emergency Department acute toxicity presentations associated with the introduction of the UK 2016 Psychoactive Substances Act.
Webb NE; Wood DM; Greene SL; Hunter LJ; Archer JRH; Dines AM; Dargan PI
Clin Toxicol (Phila); 2019 Jan; 57(1):36-41. PubMed ID: 30067112
[TBL] [Abstract][Full Text] [Related]
19. The novel psychoactive substance 3-methylmethcathinone (3-MMC or metaphedrone): A review.
Ferreira B; Dias da Silva D; Carvalho F; de Lourdes Bastos M; Carmo H
Forensic Sci Int; 2019 Feb; 295():54-63. PubMed ID: 30572220
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of use and acute toxicity associated with the use of NBOMe drugs.
Wood DM; Sedefov R; Cunningham A; Dargan PI
Clin Toxicol (Phila); 2015 Feb; 53(2):85-92. PubMed ID: 25658166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
